- Report of Foreign Issuer (6-K)
29 Oktober 2008 - 11:03AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
of
the Securities Exchange Act of 1934
28 October 2008
PROTHERICS PLC
(Translation of Registrant’s Name Into
English)
The Heath Business & Technical Park
Runcorn, Cheshire, W47 4QF England
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F
X
Form
40-F
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 191(b)(7):
Indicate by check mark whether the registrant by
furnishing the information contained in this form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under
the Securities Exchange
Act of 1934.
Yes
No
X
If “Yes” is marked, indicate below the
file number assigned to the registrant in connection with Rule 12g3-2(b):
82-
.
The Registrant is furnishing a copy of its
announcements as reported to the Company Announcements Office of the London Stock
Exchange.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
PROTHERICS PLC
|
|
|
|
|
|
|
|
Date: 28 October 2008
|
|
By:
|
|
/s/ Rolf Soderstrom
|
|
|
|
|
Rolf Soderstrom
|
|
|
|
|
Finance Director
|
Protherics PLC
Notification of Major Interest in Shares
London, UK; Brentwood, TN, US; 28
October 2008 -
Protherics PLC ("Protherics" or the "Company"), the
international biopharmaceutical company
focused on critical care and cancer, announces that the following notification of
interest in the ordinary share capital of the Company was
received today
from Aviva plc.
1. Reason for the notification
(please tick the
appropriate box or boxes)
|
|
An acquisition or disposal voting rights
|
|
An acquisition or disposal of financial instruments which may result in
the acquisition of shares already issued to which voting rights are
attached
|
|
An event changing the breakdown of voting rights
|
|
Other (please specify): INCREASE IN NUMBER OF VOTING
SHARES IN ISSUE
|
√
|
2. Full name of person(s) subject to the notification obligation:
|
Aviva plc & its subsidiaries
|
3. Full name of shareholder(s) (if different from 2.):
|
Registered Holder:
BNY Norwich Union
Nominees Limited
6,033,442*
Chase GA Group
Nominees Limited
19,592,672*
Chase Nominees Limited
881,559*
CUIM Nominee Limited
4,416,028*
Vidacos Nominees Limited
65,125*
*denotes direct interest
BNP Paribas - London
636,429
Chase Nominees Limited
3,171,774
State Street Nominees Limited
9,428,137
Vidacos Nominees
Limited
1,746,000
|
4. Date of the transaction (and date on which the threshold is crossed or
reached if different):
|
27 October 2008
|
5. Date on which issuer notified:
|
28 October 2008
|
6. Threshold(s) that is/are crossed or reached:
|
9% to 8% Change at Direct Interest level
|
7. Notified details:
|
|
A: Voting rights attached to shares
|
Class/type of
shares
if possible using
the ISIN CODE
|
Situation
previous
to the Triggering
transaction
|
Resulting
situation after the triggering
transaction
|
Number
of
Shares
|
Number
of Voting
Rights
|
Number
of
shares
|
Number of
voting
rights
|
% of voting
rights
|
Direct
|
Direct
|
Indirect
|
Direct
|
Indirect
|
Ordinary Shares
GB0007029209
|
46,722,061
|
46,722,061
|
30,988,826
|
30,988,826
|
14,982,340
|
8.84%
|
4.28%
|
B: Financial Instruments
|
Resulting situation after the triggering
transaction
|
Type of financial
instrument
|
Expiration
date
|
Exercise/
Conversion Period/
Date
|
Number of
voting
rights that may be
acquired if the
instrument is exercised/
converted.
|
% of
voting
rights
|
N/A
|
|
Total (A+B)
|
Number of voting
rights
|
% of voting
rights
|
45,971,166
|
13.12%
|
8. Chain of controlled undertakings through which the
voting rights and/or the financial
instruments are effectively held, if applicable :
|
The voting rights are managed and controlled by
Aviva Investors Global Services Limited, with the
following chain of controlled undertakings:-
Aviva Investors Global Services
Limited:
-
Aviva plc (Parent Company)
-
Aviva Group Holdings Limited (wholly
owned subsidiary of Aviva plc)
-
Aviva Investors Holdings Limited (wholly
owned subsidiary of Aviva Group Holdings Limited)
-
Aviva Investors Global Services Limited
(wholly owned subsidiary of Aviva Investors Holdings Limited)
|
Proxy Voting:
|
9. Name of the proxy holder:
|
See Section 3
|
10. Number of voting rights proxy holder will cease to hold:
|
|
11. Date on which proxy holder will cease to hold voting rights:
|
|
12. Additional information:
|
Figures
are based on a revised total number of
voting rights of 340,427,481
|
| Ends |
For further information please contact:
Protherics
|
|
Nick Staples, Director of Corporate Affairs
|
+44 (0) 7919 480510
|
Julie Vickers, Company Secretary
|
+44 (0)1928 518010
|
|
|
Financial Dynamics
- press enquiries
|
|
London: Ben Atwell, Lara Mott
|
+44 (0) 20 7831 3113
|
New York: John Capodanno
|
+1 212 850 5600
|
Or visit
www.protherics.com
Protherics (NASDAQ:PTIL)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Protherics (NASDAQ:PTIL)
Historical Stock Chart
Von Jun 2023 bis Jun 2024